Urinary system neoplasm
MONDO:0021066A benign or malignant, primary or metastatic neoplasm involving the urinary system. --2003
Also known as: neoplasm of renal system, neoplasm of the urinary system, neoplasm of the urinary tract, neoplasm of urinary system, neoplasm of urinary tract, renal system neoplasm, renal system neoplasm (disease), renal system tumor
2992 clinical trials for this condition and its sub-types, 21 tagged with Urinary system neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Urinary system neoplasm
-
Malignant urinary system neoplasm 75 trials · 1,664 incl. sub-types
10 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Urinary bladder cancer 39 trials · 682 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Multiple endocrine neoplasia type 2B 2 trials
- Malignant prostate phyllodes tumor 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Kidney neoplasm 59 trials · 860 incl. sub-types
8 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Childhood kidney neoplasm 1 trial · 30 incl. sub-types Sub-types →
- Renal pelvis neoplasm 1 trial · 24 incl. sub-types Sub-types →
- Kidney benign neoplasm 4 trials · 12 incl. sub-types Sub-types →
- Mesonephric neoplasm 1 trial · 3 incl. sub-types Sub-types →
- Kidney hemangiopericytoma 0 trials
- Mixed epithelial stromal tumor of the kidney 0 trials Sub-types →
- Multiloculated renal cyst 0 trials
-
Urinary bladder neoplasm 65 trials · 699 incl. sub-types
6 sub-types
- Urinary bladder cancer 39 trials · 682 incl. sub-types Sub-types →
- Bladder flat intraepithelial lesion 0 trials · 30 incl. sub-types Sub-types →
- Bladder papillary urothelial neoplasm 1 trial · 13 incl. sub-types Sub-types →
- Bladder benign neoplasm 0 trials Sub-types →
- Bladder inflammatory myofibroblastic tumor 0 trials
- Urinary bladder villous adenoma 0 trials
-
Urothelial neoplasm 2 trials · 693 incl. sub-types
5 sub-types
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Papillary urothelial neoplasm 0 trials · 13 incl. sub-types Sub-types →
- Urinary tract non-invasive transitional cell neoplasm 1 trial · 2 incl. sub-types Sub-types →
- Urothelial dysplasia 0 trials
-
Benign urinary system neoplasm 50 trials · 62 incl. sub-types
6 sub-types
- Kidney benign neoplasm 4 trials · 12 incl. sub-types Sub-types →
- Ureter benign neoplasm 1 trial Sub-types →
- Benign prostate phyllodes tumor 0 trials
- Benign urethral neoplasm 0 trials Sub-types →
- Bladder benign neoplasm 0 trials Sub-types →
- Urothelial papilloma 0 trials Sub-types →
-
Ureter neoplasm 2 trials · 34 incl. sub-types
3 sub-types
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Ureter benign neoplasm 1 trial Sub-types →
- Polyp of ureter 0 trials
-
Urethra neoplasm 3 trials · 31 incl. sub-types
3 sub-types
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Benign urethral neoplasm 0 trials Sub-types →
- Urethral villous adenoma 0 trials
-
Prostate phyllodes tumor 0 trials
2 sub-types
- Benign prostate phyllodes tumor 0 trials
- Malignant prostate phyllodes tumor 0 trials
Most studied deeper sub-types
-
A pill instead of surgery? trial tests vepugratinib against Low-Grade bladder cancer
Disease control Not yet recruitingResearchers are testing whether an oral drug called vepugratinib can clear low-grade, intermediate-risk bladder cancer that has not invaded muscle, or low-grade upper tract urothelial cancer. The trial enrolls adults whose tumors carry a specific change in the FGFR3 gene. Partici…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Two-Pronged immune attack shrink kidney tumors before surgery?
Disease control Not yet recruitingThis trial is testing whether giving a combination of an experimental immunotherapy (epalolitoworelimab) and a targeted therapy (lenvatinib) before and after surgery can improve outcomes for people with high-risk clear cell kidney cancer. The treatment is given first to shrink th…
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC